Risk models used to counsel women for breast and ovarian cancer: A guide for clinicians

Familial Cancer

Volumn 1, Issue 3-4, 2001, Pages 197-206

  Claus, Elizabeth B ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

ALLELE; BAYES THEOREM; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER MODEL; CANCER RISK; CANCER SUSCEPTIBILITY; DIAGNOSTIC ACCURACY; DISEASE PREDISPOSITION; GENETIC COUNSELING; GENETIC MODEL; HUMAN; LOGISTIC REGRESSION ANALYSIS; MEDICAL DECISION MAKING; MENARCHE; MENOPAUSE; MOLECULAR GENETICS; OVARY CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBABILITY; REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL;

BREAST NEOPLASMS; COUNSELING; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; HUMANS; MODELS, GENETIC; MODELS, STATISTICAL; OVARIAN NEOPLASMS; PRACTICE GUIDELINES; RISK FACTORS;

EID: 0035782837     PISSN: 13899600     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021135807900     Document Type: Review

References (50)

1. Kelsey JL, Gammon MD. Epidemiology of breast cancer. Am J Epidemiol 1990; 12: 228-40.
2. Ottman R, Pike MC, King MC et al. Familial breast cancer in a population based series. Am J Epidemiol 1986; 123: 15-21.
3. Anderson DE, Badzioch MD. Risk of familial breast cancer. Cancer 1985; 56: 383-7.
4. Sattin RW, Rubin GL, Webster LA et al. Family history and risk of breast cancer. JAMA 1985; 253: 1908-13.
5. Schwartz AG, King MC, Belle SH et al. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985; 75: 665-8.
6. Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk: The Utah Population Database. JAMA 1994; 270: 1563-8.
7. Colditz GA, Willett WC, Hunter DJ et al. Family history, age, and risk of breast cancer. JAMA 1993; 270: 338-43.
8. Claus EB, Risch N, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990; 131: 961-72.
9. Lynch HT, Watson P, Conway T et al. Breast cancer family history as a risk factor for early onset breast cancer. Br Cancer Res Treat 1988; 11: 263-7.
10. Miki Y, Swensen J, Shattuck-Eidens D et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66-71.
11. Wooster R, Neuhausen SL, Mangion J et al. Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science 1994; 265: 2088-90.
12. Claus EB, Risch N, Thompson WD. Genetic analysis of breast cancer in the Cancer and Steroid Hormone Study. Am J Hum Genet 1991; 48: 232-42.
13. Gail MH, Brinton LA. Byar DP et al. Projecting individualized probabilities of breast cancer for white females who are being examined annually. JNCI 1989; 81: 1879-86.
14. Rosner B, Colditz G. Nurses' Health Study. Log-incidence mathematical model of breast cancer incidence. J Natl Cancer Inst 1996; 88: 359-64.
15. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurse's Health Study. Amer J Epidemiol 2000; 152(10): 950-64.
16. Berry DA, Parmigiani G, Sanchez J et al. Probability of carrying a mutation of breast-ovarian cancer gene BRCA1 based on family history. J Natl Cancer Inst 1997; 89: 227-38.
17. Parmigiani G, Berry DA, Aguilar O. Determining carrier probabilities for breast cancer susceptibility genes BRCA1 and BRCA2. Am J Human Genet 1998; 62: 145-58.
18. Couch FJ, DeShano ML, Blackwood A et al. BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997; 336: 1409-15.
19. Shattuck-Eidens D, Oliphant A, McClure M et al. BRCA1 sequence analysis in women at high risk for susceptibility mutations. JAMA 1997; 278: 1242-50,
20. Ford D, Easton DF, Peto J, Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57: 1457-62.
21. Easton D, Ford D, Bishop DT and the Breast Cancer Linkage Consortium. Breast and ovarian cancer incidence in BRCA1 mutation carriers. Am J Hum Genet 1995; 56: 265-71.
22. Struewing JP, Abeliovich D, Peretz T et al. The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals. Nat Genet 1995; 11: 198-200.
23. Schottenfeld D, Fraumeni JF Jr (eds). Cancer Epidemiology and Prevention, 2nd Edition. New York, NY: Oxford University Press, 1996.
24. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: The Nurses' Health Study. Am J Epidemiol 1994; 139: 819-35.
25. Constantino J, Gail MH, Pee D et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. JNCI 1998; 90: 1371-88.
26. Fisher B, Constantino JP, Wickerham DL et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998; 90: 1371-88.
27. Breast Cancer Risk Assessment Tool, National Cancer Institute website. http://bcra.nci.nih.gov.
28. Pike MC, Krailo MD, Henderson BE et al. Hormonal risk factors, breast tissue age, and the age-incidence of breast cancer. Nature 1983; 303: 767-70.
29. Moolgavkar SH, Day NE. Stevens RG. Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J Natl Cancer Inst 1980; 65: 559-69.
30. Claus EB, Risch N, Thompson WD. Autosomal dominant inheritance of early onset breast cancer: Implications for risk prediction. Cancer 1994; 73: 643-51.
31. Claus EB, Thompson WD, Risch N. The calculation of breast cancer risk for women with a first degree family history of ovarian cancer. Br Cancer Res Treat 1993; 28: 115-20.
32. CancerGene at http://www3.utsouthwestern.edu/cancergene.
33. The Prevalence of Deletrious Mutations in BRCA2 and BRCA2. Myriad Genetics, Inc., 2001. Available at: http://www.myriad.com/med/brac/mutptables.html.
34. Gail MH, Benichou J. Assessing the risk of breast cancer in individuals. In Devita VT. Hellman S, Rosenberg SA (eds), Cancer Prevention. Philadelphia, PA: Lippincott, 1992: 1-15.
35. Bondy ML, Lustbader ED, Halabi S et al. Validation of a breast cancer risk assessment model in women with a positive family history. J Natl Cancer Inst 1994; 86: 620-5.
36. Vogel V, Mondy M, Halabi S et al. Validation of Gail's breast cancer risk model. Proc ASCO 1993; 12: 167.
37. Spiegelman D, Colditz GA, Hunter D, Hertzmark E. Validation of the Gail et al. model for predicting individualized breast cancer risk. J Natl Cancer Inst 1994; 86: 600-7.
38. Rockhill B, Spiegelman D, Byrne C et al. Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention. JNCI 2001; 93: 358-66.
39. McGuigan KA, Ganz PA, Breant C. Agreement between breast cancer risk estimation methods. J Natl Cancer Inst 1996; 88: 1315-6.
40. Euhus DM, Smith KC, Robinson L et al. Pretest prediction of BRCA1 or BRCA2 mutation by risk counselors and the computer model BRCAPRO. JNCI 2002; 94: 844-51.
41. Hilsenbeck SG, Wenger CR, Reynolds LP et al. Early results of genetic testing for breast cancer susceptibility. Br Cancer Res Treat 1997; 46: 38.
42. Hiller EH, Parmigiani G, Berry DA et al. Validity testing of a computer model for calculating carrier probabilities of BRCA1 and BRCA2 mutations, Abstract presented at the 1997, meeting of the ASHG.
43. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990; 46: 813-26.
44. Benichou J, Gail MH. Methods of inference for estimates of absolute risk derived from population-based case-control studies. Biometrics 1995; 51: 182-94.
45. Benichou J, Gail M, Mulvihill JJ. Graphs to estimate an individualized risk of breast cancer. J Clin Oncol 1996; 14: 103-10.
46. Hoskins KF, Stopfer JE, Calzone KA et al. Assessment and counseling for women with a family history of breast cancer: A guide for clinicians. JAMA 1995; 273: 577-85.
47. McTiernan A, Gilligan MA, Redmond C. Assessing individual risk for breast cancer: Risky business. J Clin Epidemiol 1997; 50: 547-56.
48. Offit K, Brown K. Quantitating familial cancer risk: A resource for clinical oncologists. J Clin Oncol 1994; 12: 1724-36.
49. Biesecker BB, Boehnke M, Calzone K et al. Genetic counseling for families with inherited susceptibility to breast and ovarian cancer. JAMA 1993; 269: 1970-74.
50. Parmigiani G, Berry DA, Iversen E et al. Modeling risk of breast cancer and decisions about genetic testing. Fourth Workshop on Case Studies in Bayesian Statistics. Pittsburgh, PA, September 26-27, 1997.